Medical NewsGerman Drug Data (Deutsch)
Norwegian Drug Data (Norge)
Netherlands Drug Data (Nederlands)
Swedish Drug Data (Sverige)
Want to submit or suggest content for the epgonline.org YouTube Clinical channel?
Contact us here
epgonline.org is not responsible for content on any 3rd party website
Please register to access disease diagnosis, patient management, physician tools.
By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.
| Drug class description : | Antivirals. |
| Generic Name : | Famciclovir - genital herpes |
| Drug description : | White f-c tablets. |
| Presentation : | Tablets, famciclovir 125 mg , 250 mg , 500 mg . |
| Indications : | Treatment of acute genital herpes infections and suppression of recurrent genital herpes infections in immunocompetent and immunocompromised patients. |
| Adult Dosage : | First attack, 250 mg three times daily for 5 days started as soon as possible after onset of lesions. In immunocompromised, 500 mg twice daily for 7 days. Recurrent attacks, 125 mg twice daily for 5 days. In immunocompromised, 500 mg twice daily for 7 days. Start treatment during prodromal period or as soon as possible after onset of lesions. Suppression, 250 mg twice daily. In HIV patients, 500 mg twice daily. Interrupt therapy at 6 - 12 month intervals to reassess. |
| Child Dosage : | Not recommended. |
| Contra Indications : | Known hypersensitivity to famciclovir or other constituents. |
| Special Precautions : | Renal impairment. Pregnancy, lactation. |
| Adverse Reactions : | Headache, nausea. Rarely, vomiting, dizziness, skin rash and confusion. |
| Manufacturer : | GlaxoSmithKline(GSK) |
| Drug Availability : | (POM) |
Only registered users have access to the full EPG Online Knowledge Base including drug search tools, interactive disease Knowledge Centres via the EPG Knowledge Library - with clinical and evidence based physician and research tools, MiMedia (build your own clinical media collection with everything from key opinion leader essays to mode of action videos and other multi-media content), the EPG Survey panel, health news updates and much much more.
Already Registered?
Please log-in now using our member login box.
Not a member?
Don't worry, registration is quick and FREE! We welcome all Healthcare professionals, doctors, nurses and medical students.
Register today to have full access to a wealth of drug data, educational and evidence based interactive guides across all major therapeutic areas, disease management, and clinical tools.
As a practicing Healthcare professional, you can also opt-in to join our market research panel – www.epgsurvey.com – and get paid for sharing your expert clinical opinions!
REGISTER today it only takes a minute! and it's FREE
Having problems?
Use our forgotten password facility or email us at: contact@epgonline.org